SCHEMBL1722353

SCHEMBL1722353

CCSc1nc2ccccc2c(C)c1N1C(=O)c2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 2/20 0.43
ELANE P08246 1/20 0.43
KDM4E B2RXH2 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALDH1A1 P00352 2/20 0.41
MAPT P10636 3/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PDE10A Q9Y233 1/20 0.40
TSHR P16473 2/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PTK2B Q14289 1/20 0.38
ALPL P05186 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1721513 0.77 KMT2A (0.42) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL8109351 0.76 ALDH1A1 (0.47) KDM4EALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL1722601 0.75 KDM4E (0.41) PDE7AELANEKDM4ERXFP1TDP1
SCHEMBL3110055 0.71 PDE10A (0.56) ELANEKDM4ERXFP1TDP1ALDH1A1
SCHEMBL8109356 0.67 GRM5 (0.43) KDM4ERXFP1TDP1MAPTNPC1
SCHEMBL12204686 0.66 KMT2A (0.53) ALDH1A1TSHRMEN1KMT2A
SCHEMBL20885167 0.62 KMT2A (0.57) KDM4ERXFP1ALDH1A1RAB9AMEN1
SCHEMBL9601532 0.61 MAPT (0.41) PDE7AELANEKDM4EALDH1A1MAPT
SCHEMBL8986839 0.61 PDE7A (0.68) PDE7AKDM4ETDP1ALDH1A1NPC1
SCHEMBL15195139 0.61 PDE7A (0.68) PDE7AKDM4ETDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406228-B1 Substituted 3-amino-2-mercaptochinolins as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-09-18 EP disclosed
US-8207342-B2 Substituted 3-amino-2-mercaptoquinolines as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2012-06-26 US disclosed
EP-2406228-A1 SUBSTITUTED 3-AMINO-2-MERCAPTOQUINOLINES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2012-01-18 EP disclosed
WO-2010102779-A1 SUBSTITUTED 3-AMINO-2-MERCAPTOQUINOLINES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2010-09-16 WO disclosed
US-20100234421-A1 SUBSTITUTED 3-AMINO-2-MERCAPTOQUINOLINES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234421-A1 SUBSTITUTED 3-AMINO-2-MERCAPTOQUINOLINES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNQ3 PDE7A 2879/4885ELANE 4806/4885KDM4E 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.